NALTREXONE PLUS KETAMINE FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER AND ALCOHOL USE DISORDER

被引:0
|
作者
Yoon, G. [1 ]
Ralevski, E. [1 ]
Arias, A. J. [1 ]
Limoncelli, D. [1 ]
Newcomb, J. [1 ]
Levy, L. [1 ]
Jane, J. S. [1 ]
Krystal, J. H. [1 ]
Petrakis, I. L. [1 ]
机构
[1] Yale Univ, Dept Psychiat, VA Connecticut Healthcare Syst, West Haven, CT 06516 USA
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
869
引用
收藏
页码:236A / 236A
页数:1
相关论文
共 50 条
  • [1] REPEATED KETAMINE TREATMENT FOR COMORBID MAJOR DEPRESSIVE DISORDER AND ALCOHOL USE DISORDER
    Yoon, G.
    Ralevski, E.
    Abdallah, C. G.
    Arias, A. J.
    Limoncelli, D.
    Newcomb, J.
    Jane, J. S.
    Sofuoglu, M.
    Krystal, J. H.
    Petrakis, I. L.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 : 97A - 97A
  • [2] Ketamine in the Treatment of Major Depressive Disorder
    Luu, Brent
    Rice, Elizabeth
    Goldin, Philippe
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2020, 16 (03): : 228 - 231
  • [3] Naltrexone May Attenuate the Effect of Acamprosate in Patients With Alcohol Use Disorder and Major Depressive Disorder
    Ou, Hsun
    Chen, Chun-Yen
    AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (06) : E580 - E581
  • [4] KETAMINE AS A TREATMENT FOR ADOLESCENT MAJOR DEPRESSIVE DISORDER
    Dwyer, Jennifer B.
    Bloch, Michael H.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S176 - S176
  • [5] Ketamine as a Treatment for Adolescent Major Depressive Disorder
    Dwyer, Jennifer
    Sanacora, Gerard
    Bloch, Michael
    BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S405 - S405
  • [6] Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case Series of Patients With Depression and Alcohol Use Disorder
    Yoon, Gihyun
    Petrakis, Ismene L.
    Krystal, John H.
    JAMA PSYCHIATRY, 2019, 76 (03) : 337 - 338
  • [7] The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder
    Chadi G Abdallah
    Andrea Jackowski
    Ramiro Salas
    Swapnil Gupta
    João R Sato
    Xiangling Mao
    Jeremy D Coplan
    Dikoma C Shungu
    Sanjay J Mathew
    Neuropsychopharmacology, 2017, 42 : 1739 - 1746
  • [8] The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder
    Abdallah, Chadi G.
    Jackowski, Andrea
    Salas, Ramiro
    Gupta, Swapnil
    Sato, Joao R.
    Mao, Xiangling
    Coplan, Jeremy D.
    Shungu, Dikoma C.
    Mathew, Sanjay J.
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 (08) : 1739 - 1746
  • [9] Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
    Rong, Carola
    Park, Caroline
    Rosenblat, Joshua D.
    Subramaniapillai, Mehala
    Zuckerman, Hannah
    Fus, Dominika
    Lee, Yena L.
    Pan, Zihang
    Brietzke, Elisa
    Mansur, Rodrigo B.
    Cha, Danielle S.
    Lui, Leanna M. W.
    McIntyre, Roger S.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2018, 15 (04):
  • [10] Intravenous Ketamine for Treatment-Resistant Major Depressive Disorder
    Covvey, Jordan R.
    Crawford, Alexis Noble
    Lowe, Denise K.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (01) : 117 - 123